Developer docs
API playgroundTry for free, no card

Search company profiles

Perimeter

Full company profile

uuid00py8gb

Namestring
Perimeter
Legal namestring
Perimeter Systems, Inc.
Websiteurl
perimeter.bio
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Perimeter Systems, Inc. is a Boston-based biosecurity infrastructure company that builds the Biothreat Radar platform for government agencies, defense organizations, healthcare systems, and public health authorities. The platform integrates four core modules—Detect, Characterize, Respond, and Forecast—through a global network of biosurveillance nodes spanning airports, hospitals, municipal wastewater systems, and critical infrastructure across the United States, Africa, the Middle East, Ukraine, and Georgia. The Traveler-Based Genomic Surveillance (TGS) program operates across 8 international airports covering 135+ countries of origin, having collected samples from over one million international traveler volunteers and 2,600+ wastewater samples since 2021. The company's go-to-market is exclusively direct enterprise and government sales, with quote-based contract pricing and no self-serve or consumer motion.

The company's technical foundation rests on proprietary capabilities including ENDAR (Engineered Nucleotide Detection and Ranking), a first-of-its-kind analysis toolkit developed under the IARPA FELIX program that distinguishes genetic engineering from natural evolution or sequencing noise at sensitivity down to 50 base pairs and up to 10x back-dilution. ENDAR was ranked first among dry lab performers in the FELIX program and validated through four test and evaluation exercises with US National Laboratories. The Characterize module combines computational biology with frontier AI to assess pathogen risk, while the Forecast module provides custom risk models with off-the-shelf models available for measles, avian influenza, Marburg virus, and foot-and-mouth disease. Demonstrated outcomes include identifying H3N2 subclade K seven days before public repository appearance in August 2025, developing a pan-clade Mpox PCR assay within three weeks when standard diagnostics failed, and detecting vancomycin-resistant Enterococci a full week before clinical identification at a military treatment facility.

Perimeter generates revenue through subscription-based and managed-services contracts with government and institutional customers for biosurveillance and biothreat intelligence services, with pricing negotiated directly rather than publicly disclosed. In April 2026, the company acquired substantially all of Ginkgo Bioworks' Biosecurity business in exchange for a minority equity stake and closed a $60M financing round led by Kanders & Company with participation from Four Cities Capital, Goldcrest Capital, Safe AI Fund, and SCS Financial. Customers referenced in source materials include the California Department of Public Health, Defense Centers for Public Health-Aberdeen, the Association of Public Health Laboratories (APHL), and U.S. Military Treatment Facilities.

Short descriptiontext

Perimeter Systems, Inc. is a Boston-based biosecurity infrastructure company that builds the Biothreat Radar platform for government agencies, defense organizations, and public health authorities to detect, characterize, and respond to biological threats across a global surveillance network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biosecurity infrastructure, pathogen genomic surveillance, biothreat detection, biosurveillance platform, wastewater monitoring
Industry2 codes
PRIMARYHLAJAIAL
Biothreat/Biocontainment & Select Agent Public Health Laboratories
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Biosecurity Infrastructure
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Biosecurity Infrastructure Services
TypeSubscription Recurring
Description

Subscription or contract-based biosurveillance and biothreat intelligence services deployed across airports, hospitals, military installations, and critical infrastructure. Revenue derived from government and institutional contracts for threat detection, characterization, and response guidance.

perimeter.bio
2Custom Monitoring Programs
TypeManaged Services
Description

Tailored biosurveillance programs for specific operational environments (e.g., military treatment facilities, conflict zones). Revenue from specialized deployments and ongoing monitoring services.

perimeter.bio
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1ENDAR
Description

Engineered Nucleotide Detection and Ranking system - a first-of-its-kind analysis toolkit that distinguishes genetic engineering from natural evolution or sequencing noise, developed in collaboration with IARPA under the FELIX program.

perimeter.bio
Core offering1 text field

Perimeter operates a Biothreat Radar platform that combines distributed physical sampling (airports, hospitals, wastewater, critical infrastructure), metagenomic sequencing, and AI-enabled computational biology to forecast, detect, characterize, and respond to biological threats. It delivers always-on biosurveillance, genetic engineering detection through the proprietary ENDAR toolkit, predictive risk modeling, and tailored intelligence products for government, defense, healthcare, and public health customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Identified novel H3N2 subclade K seven days before public repository appearance, enabling proactive public health response
+3 more records
Product overview1 text field

Perimeter offers a unified biosecurity platform called the Biothreat Radar, which integrates four core modules—Detect, Characterize, Respond, and Forecast—to provide comprehensive biothreat intelligence. Detect enables layered collection through global biosurveillance nodes; Characterize combines computational biology with AI for risk assessment and genetic engineering detection; Respond synthesizes intelligence for decisive action; and Forecast provides predictive risk modeling. The platform is enhanced by specialized capabilities including ENDAR for engineered nucleotide detection and the TGS Program for airport-based genomic surveillance. A pan-clade wastewater PCR assay developed for Mpox is also available as an off-the-shelf kit.

Product and service4 records
1Biothreat Radar Platform
CategoryBiosurveillance Platform
Description

Always-on biosurveillance platform that forecasts and detects biological threats as they emerge, characterizes risk for specific operational contexts, and guides intelligent response for government agencies, defense organizations, healthcare systems, and public health authorities.

2TGS (Traveler-Based Genomic Surveillance) Program
CategoryGenomic Surveillance Program
Description

Traveler-based genomic surveillance network operating across 8 international airports covering 135+ countries of origin, with over one million international traveler volunteers and 2,600+ wastewater samples collected since 2021 to detect emerging health threats and track new variants.

3ENDAR (Engineered Nucleotide Detection and Ranking)
CategoryBioinformatics Toolkit
Description

Proprietary analysis toolkit that distinguishes genetic engineering from natural evolution or sequencing noise, detecting genetic manipulations as small as 50 base pairs in viruses, bacteria, fungi, and plants, and detecting engineered material at up to 10x back-dilution into non-engineered parental strains.

4Pan-Clade Wastewater PCR Assay
CategoryDiagnostic Assay Kit
Description

Wastewater PCR assay kit for detecting Mpox Clade Ib, developed within approximately 3 weeks, validated by Defense Centers for Public Health-Aberdeen, and available as an off-the-shelf product through the Association of Public Health Laboratories (APHL).

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1IARPA (Intelligence Advanced Research Projects Activity)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration under the FELIX (Finding Engineering-Linked Indicators) program to develop ENDAR - a first-of-its-kind analysis toolkit for distinguishing genetic engineering from natural evolution. ENDAR ranked first among dry lab performers in the FELIX program and was validated through 4 T&E exercises with US National Labs. This partnership established Perimeter's technical leadership in genetic engineering detection.

perimeter.bio
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distributes Perimeter's pan-clade wastewater PCR assay kit for Mpox detection, making the validated assay available as an off-the-shelf product to public health laboratories nationwide. Kit also validated by Defense Centers for Public Health-Aberdeen.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Perimeter acquired Ginkgo Bioworks' Biosecurity business unit on April 3, 2026, receiving substantially all Biosecurity operations in exchange for a minority equity stake in Perimeter. This acquisition expanded Perimeter's biosecurity infrastructure capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Government services and defense contractor with biosurveillance and CBRN (chemical, biological, radiological, nuclear) defense capabilities. Competes for federal biosecurity programs alongside Perimeter.

TypeBroad incumbent
Description

Federal IT and engineering services provider with biosurveillance and threat intelligence offerings for defense and intelligence community customers. Overlaps with Perimeter's government-facing biosecurity infrastructure.

TypeBroad incumbent
Description

Large federal contractor with health and biodefense capabilities including biosurveillance and threat characterization. Competes with Perimeter for defense and public health agency contracts, though as part of a much broader portfolio.

TypeDirect peer
Description

Synthetic biology platform company that spun/contributed its Biosecurity business to Perimeter in April 2026 in exchange for a minority equity stake. Closely tied commercially and strategically, with overlapping biosecurity infrastructure heritage.

TypeBroad incumbent
Description

Molecular diagnostics and sample preparation technologies company serving public health, biosecurity, and research customers. Comparable to Perimeter on the laboratory assay and pathogen detection tooling layer.

TypeEmerging player
Description

Molecular diagnostics company (part of Danaher) with rapid PCR testing systems used in public health, hospital, and biodefense settings. Comparable on the pathogen diagnostic technology stack that Perimeter integrates and extends.

TypeBroad incumbent
Description

Global in vitro diagnostics company with strong pathogen detection and syndromic testing panels (FilmArray/BioFire). Comparable to Perimeter on the infectious disease detection side, particularly for hospital and public health lab customers.

TypeBroad incumbent
Description

Nonprofit applied science organization with deep biodefense research and biosurveillance capabilities for government customers. Directly comparable on biothreat detection R&D and federal contract work.

TypeDirect peer
Description

Direct biosurveillance and pandemic risk analytics peer now operating within Booz Allen Hamilton. Offers epidemic risk monitoring and early warning capabilities very similar to Perimeter's Biothreat Radar, targeting government, insurance, and public health customers.

TypeBroad incumbent
Description

Major government services contractor with a biosurveillance and biodefense practice (notably via its acquisition of Metabiota). Competes for the same federal biosurveillance contracts that Perimeter serves, but as a much larger, diversified prime contractor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Perimeter

Biosecurity Infrastructureperimeter.bio

Perimeter Systems, Inc. is a Boston-based biosecurity infrastructure company that builds the Biothreat Radar platform for government agencies, defense organizations, and public health authorities to detect, characterize, and respond to biological threats across a global surveillance network.

What Perimeter does

Perimeter Systems, Inc. is a Boston-based biosecurity infrastructure company that builds the Biothreat Radar platform for government agencies, defense organizations, healthcare systems, and public health authorities. The platform integrates four core modules—Detect, Characterize, Respond, and Forecast—through a global network of biosurveillance nodes spanning airports, hospitals, municipal wastewater systems, and critical infrastructure across the United States, Africa, the Middle East, Ukraine, and Georgia. The Traveler-Based Genomic Surveillance (TGS) program operates across 8 international airports covering 135+ countries of origin, having collected samples from over one million international traveler volunteers and 2,600+ wastewater samples since 2021. The company's go-to-market is exclusively direct enterprise and government sales, with quote-based contract pricing and no self-serve or consumer motion.

The company's technical foundation rests on proprietary capabilities including ENDAR (Engineered Nucleotide Detection and Ranking), a first-of-its-kind analysis toolkit developed under the IARPA FELIX program that distinguishes genetic engineering from natural evolution or sequencing noise at sensitivity down to 50 base pairs and up to 10x back-dilution. ENDAR was ranked first among dry lab performers in the FELIX program and validated through four test and evaluation exercises with US National Laboratories. The Characterize module combines computational biology with frontier AI to assess pathogen risk, while the Forecast module provides custom risk models with off-the-shelf models available for measles, avian influenza, Marburg virus, and foot-and-mouth disease. Demonstrated outcomes include identifying H3N2 subclade K seven days before public repository appearance in August 2025, developing a pan-clade Mpox PCR assay within three weeks when standard diagnostics failed, and detecting vancomycin-resistant Enterococci a full week before clinical identification at a military treatment facility.

Perimeter generates revenue through subscription-based and managed-services contracts with government and institutional customers for biosurveillance and biothreat intelligence services, with pricing negotiated directly rather than publicly disclosed. In April 2026, the company acquired substantially all of Ginkgo Bioworks' Biosecurity business in exchange for a minority equity stake and closed a $60M financing round led by Kanders & Company with participation from Four Cities Capital, Goldcrest Capital, Safe AI Fund, and SCS Financial. Customers referenced in source materials include the California Department of Public Health, Defense Centers for Public Health-Aberdeen, the Association of Public Health Laboratories (APHL), and U.S. Military Treatment Facilities.

Perimeter firmographics

Firmographics
Name
Perimeter
Legal name
Perimeter Systems, Inc.
Website
https://perimeter.bio
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Perimeter Systems, Inc. is a Boston-based biosecurity infrastructure company that builds the Biothreat Radar platform for government agencies, defense organizations, and public health authorities to detect, characterize, and respond to biological threats across a global surveillance network.
Ownership category
akta.pro rank

Perimeter industry classification

Industry
Product category
Biosecurity Infrastructure
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAJAIAL
Biothreat/Biocontainment & Select Agent Public Health Laboratories
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Biosecurity infrastructure
  • Pathogen genomic surveillance
  • Biothreat detection
  • Biosurveillance platform
  • Wastewater monitoring

Where Perimeter is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Perimeter business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Biosecurity Infrastructure Services: Subscription or contract-based biosurveillance and biothreat intelligence services deployed across airports, hospitals, military installations, and critical infrastructure. Revenue derived from government and institutional contracts for threat detection, characterization, and response guidance.
  2. Custom Monitoring Programs: Tailored biosurveillance programs for specific operational environments (e.g., military treatment facilities, conflict zones). Revenue from specialized deployments and ongoing monitoring services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Perimeter product offering

Product offering

Core offering

Perimeter operates a Biothreat Radar platform that combines distributed physical sampling (airports, hospitals, wastewater, critical infrastructure), metagenomic sequencing, and AI-enabled computational biology to forecast, detect, characterize, and respond to biological threats. It delivers always-on biosurveillance, genetic engineering detection through the proprietary ENDAR toolkit, predictive risk modeling, and tailored intelligence products for government, defense, healthcare, and public health customers.

Product overview

Perimeter offers a unified biosecurity platform called the Biothreat Radar, which integrates four core modules—Detect, Characterize, Respond, and Forecast—to provide comprehensive biothreat intelligence. Detect enables layered collection through global biosurveillance nodes; Characterize combines computational biology with AI for risk assessment and genetic engineering detection; Respond synthesizes intelligence for decisive action; and Forecast provides predictive risk modeling. The platform is enhanced by specialized capabilities including ENDAR for engineered nucleotide detection and the TGS Program for airport-based genomic surveillance. A pan-clade wastewater PCR assay developed for Mpox is also available as an off-the-shelf kit.

Differentiator

Problem solved

Functional benefit

Brands

  • ENDAR: Engineered Nucleotide Detection and Ranking system - a first-of-its-kind analysis toolkit that distinguishes genetic engineering from natural evolution or sequencing noise, developed in collaboration with IARPA under the FELIX program.

Products and services

  • Biothreat Radar Platform Always-on biosurveillance platform that forecasts and detects biological threats as they emerge, characterizes risk for specific operational contexts, and guides intelligent response for government agencies, defense organizations, healthcare systems, and public health authorities.
  • TGS (Traveler-Based Genomic Surveillance) Program Traveler-based genomic surveillance network operating across 8 international airports covering 135+ countries of origin, with over one million international traveler volunteers and 2,600+ wastewater samples collected since 2021 to detect emerging health threats and track new variants.
  • ENDAR (Engineered Nucleotide Detection and Ranking) Proprietary analysis toolkit that distinguishes genetic engineering from natural evolution or sequencing noise, detecting genetic manipulations as small as 50 base pairs in viruses, bacteria, fungi, and plants, and detecting engineered material at up to 10x back-dilution into non-engineered parental strains.
  • Pan-Clade Wastewater PCR Assay Wastewater PCR assay kit for detecting Mpox Clade Ib, developed within approximately 3 weeks, validated by Defense Centers for Public Health-Aberdeen, and available as an off-the-shelf product through the Association of Public Health Laboratories (APHL).

Quantifiable outcome

  • Identified novel H3N2 subclade K seven days before public repository appearance, enabling proactive public health response
  • +3 more outcomes

Companies that use Perimeter

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Perimeter technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Perimeter partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • IARPA (Intelligence Advanced Research Projects Activity)coreStrategic or Co-development PartnerCollaboration under the FELIX (Finding Engineering-Linked Indicators) program to develop ENDAR - a first-of-its-kind analysis toolkit for distinguishing genetic engineering from natural evolution. ENDAR ranked first among dry lab performers in the FELIX program and was validated through 4 T&E exercises with US National Labs. This partnership established Perimeter's technical leadership in genetic engineering detection.
  • Association of Public Health Laboratories (APHL)coreChannel Partner/ Reseller/ DistributorDistributes Perimeter's pan-clade wastewater PCR assay kit for Mpox detection, making the validated assay available as an off-the-shelf product to public health laboratories nationwide. Kit also validated by Defense Centers for Public Health-Aberdeen.
  • Ginkgo BioworksminorStrategic or Co-development PartnerPerimeter acquired Ginkgo Bioworks' Biosecurity business unit on April 3, 2026, receiving substantially all Biosecurity operations in exchange for a minority equity stake in Perimeter. This acquisition expanded Perimeter's biosecurity infrastructure capabilities.

Scale indicators10 records

Recent moves6 records

Expansion highlights7 records

Perimeter competitors and assessment

Company assessment

Broad incumbents

  • Parsons Corporation: Government services and defense contractor with biosurveillance and CBRN (chemical, biological, radiological, nuclear) defense capabilities. Competes for federal biosecurity programs alongside Perimeter.
  • CACI International: Federal IT and engineering services provider with biosurveillance and threat intelligence offerings for defense and intelligence community customers. Overlaps with Perimeter's government-facing biosecurity infrastructure.
  • Leidos: Large federal contractor with health and biodefense capabilities including biosurveillance and threat characterization. Competes with Perimeter for defense and public health agency contracts, though as part of a much broader portfolio.
  • QIAGEN: Molecular diagnostics and sample preparation technologies company serving public health, biosecurity, and research customers. Comparable to Perimeter on the laboratory assay and pathogen detection tooling layer.
  • bioMérieux (BioFire Diagnostics): Global in vitro diagnostics company with strong pathogen detection and syndromic testing panels (FilmArray/BioFire). Comparable to Perimeter on the infectious disease detection side, particularly for hospital and public health lab customers.
  • Battelle Memorial Institute: Nonprofit applied science organization with deep biodefense research and biosurveillance capabilities for government customers. Directly comparable on biothreat detection R&D and federal contract work.
  • Booz Allen Hamilton: Major government services contractor with a biosurveillance and biodefense practice (notably via its acquisition of Metabiota). Competes for the same federal biosurveillance contracts that Perimeter serves, but as a much larger, diversified prime contractor.

Direct peers

  • Ginkgo Bioworks: Synthetic biology platform company that spun/contributed its Biosecurity business to Perimeter in April 2026 in exchange for a minority equity stake. Closely tied commercially and strategically, with overlapping biosecurity infrastructure heritage.
  • Metabiota (a Booz Allen Hamilton company): Direct biosurveillance and pandemic risk analytics peer now operating within Booz Allen Hamilton. Offers epidemic risk monitoring and early warning capabilities very similar to Perimeter's Biothreat Radar, targeting government, insurance, and public health customers.

Emerging players

  • Cepheid (Danaher): Molecular diagnostics company (part of Danaher) with rapid PCR testing systems used in public health, hospital, and biodefense settings. Comparable on the pathogen diagnostic technology stack that Perimeter integrates and extends.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Perimeter social profiles

Digital presence

Perimeter financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Perimeter leadership team

Management profile

Number of profiles

Perimeter funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Perimeter M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Perimeter

What does Perimeter do?

Perimeter operates a Biothreat Radar platform that combines distributed physical sampling (airports, hospitals, wastewater, critical infrastructure), metagenomic sequencing, and AI-enabled computational biology to forecast, detect, characterize, and respond to biological threats. It delivers always-on biosurveillance, genetic engineering detection through the proprietary ENDAR toolkit, predictive risk modeling, and tailored intelligence products for government, defense, healthcare, and public health customers.

Is Perimeter a public or private company?

Perimeter is a private company. It is classified as venture growth investor backed and is currently operating.

When was Perimeter founded?

Perimeter was founded in 2019. It employs 51 to 100 people.

Where is Perimeter based?

Perimeter is headquartered in Boston, United States, in the North America region.

How does Perimeter make money?

Two revenue lines are on record. Biosecurity Infrastructure Services are the primary driver. The others are custom Monitoring Programs.

Who are Perimeter's main competitors?

Broad incumbents on record are Parsons Corporation, CACI International, Leidos, QIAGEN, bioMérieux (BioFire Diagnostics), Battelle Memorial Institute and Booz Allen Hamilton. Direct peers are Ginkgo Bioworks and Metabiota (a Booz Allen Hamilton company). Cepheid (Danaher) is listed as an emerging player.

Does Perimeter have an API?

No public API is recorded for Perimeter.

What industry is Perimeter in?

Perimeter's product category is Biosecurity Infrastructure. Its primary akta.pro industry code is HLAJAIAL, Biothreat/Biocontainment & Select Agent Public Health Laboratories, with a secondary code of HLAGAEAF, Microbiology & Infectious Disease Testing (Trial Support). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN Presswire5 Founders Under 30 Share the Best Advice They’ve Followed — And What They're Glad They IgnoredFive under-30 founders from Maverick NEXT shared advice on business, including Bailey Farren's Perimeter software and Sean Meer's Cleantech Inc. They also discussed how inexperience can be an advantage and how doing good drives revenue. The article promotes the Maverick NEXT Impact Award, with applications due November 30.Medical Device NetworkPerimeter and Culturewell launch hospital infection surveillance programmeBiosecurity specialist Perimeter and outbreak detection company Culturewell have launched a joint infection surveillance programme to help hospitals identify and mitigate healthcare-associated infections. The partnership combines Culturewell’s room-level surface sampling with Perimeter’s building-level wastewater sequencing to provide continuous, multi-level views of infection risk. This initiative aims to deliver earlier warnings and a more robust evidence base for protecting patients compared to single monitoring layers.SNS InsiderPerimeter Systems Launches Global Biosecurity EraPerimeter Systems, Inc. has launched a global biosecurity infrastructure platform designed to convert biological signals into real-time actionable intelligence using artificial intelligence. The company secured $60 million in growth capital from investors including Kanders & Company to accelerate the development and deployment of its scalable detection systems.AijournPerimeter Systems, Inc. Launches as Global, End-to-End Biosecurity Infrastructure Platform to Address Escalating Global Biodefense NeedsPerimeter Systems, Inc. launched as a standalone company building the world's first integrated biosecurity infrastructure platform, with $60 million in growth capital secured from Kanders & Company, SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund. The company provides end-to-end biosecurity capabilities spanning detection, identification, monitoring, and analytics powered by frontier AI, serving customers and national security agencies across the U.S. Government enterprise and more than 10 countries. The platform is already deployed at critical infrastructure locations including international airports, conflict zones, transit hubs, and municipal wastewater systems to convert biological data into real-time biointelligence for governments and enterprises.PR NewswirePerimeter Systems, Inc. Launches as Global, End-to-End Biosecurity Infrastructure Platform to Address Escalating Global Biodefense NeedsPerimeter Systems, Inc. launched as a standalone global biosecurity infrastructure platform with $60 million in growth capital secured from Kanders & Company, SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund. The end-to-end platform provides AI-powered detection, identification, monitoring, and analytics capabilities for governments and enterprises, with active programs deployed at critical infrastructure locations including international airports, conflict zones, transit hubs, and municipal wastewater systems across the U.S. Government enterprise and more than 10 countries. Founded by Matt McKnight, previously General Manager of Ginkgo Biosecurity and Chief Commercial Officer at Ginkgo Bioworks, the company aims to address the expanding biological risk landscape driven by AI-biotechnology convergence, proliferation of high-containment laboratories, and intensifying geopolitical competition.